C. S. Pramesh Has Been Elected UICC President-Elect for the 2026–2028 Term
FDA Grants Accelerated Approval: Dostarlimab for MSI-H/dMMR Locally Advanced Rectal Cancer
A Defining Moment for Cancer Immunotherapy During ESMO 2026 - Agenus
RASolve 308: Phase III Trial Tests Zoldonrasib With Pembrolizumab and Chemotherapy in First-Line RAS G12D NSCLC
ESMO 2026: 5 Phase III Immunotherapy Trials to Watch
Tattoos and Cancer: Is There a Link to Skin Cancer and Lymphoma?
Revolution Medicines Begins Phase 3 RASolve 308 Trial of Zoldonrasib in RAS G12D Non-squamous NSCLC
Bari, 1943: The Disaster That Changed Cancer Treatment
